Their non Covid kit margins were always above 50%. as Covid kits were sold like commodity in later stages due to volume play, it is not comparable.
In starting years consolidated margins were lower due to lower contribution of 3bb… but as company is converting into biotech, it gonna sustain atleast in short term unless there is stiff competition in future.
| Subscribe To Our Free Newsletter |
